XClose

UCL Great Ormond Street Institute of Child Health

Home
Menu

Clinical Neurosciences

Strategic aim: To minimise the clinical impact of neurological disease by improving diagnosis, studying disease mechanisms and evaluating novel therapeutic strategies

Groups focus on epilepsy, cerebrovascular disease, movement disorder, neurometabolic disease, demyelinating disease and visual impairment. The section employs varies research methodologies including molecular genetic research, clinical trials and epidemiological studies.

Epidemiology
Pathogenesis
Outcomes
Novel treatments and other intervention
Pain

Strategic view: To maximize the current research programme, and develop further in all domains, and to achieve improved outcomes in childhood neurological disease. We aim to expand our expertise in detailed clinical phenotyping that is the essential prerequisite for accurate mechanistic and outcome studies. Our links to Vermont enable development and investigation of clinically relevant animal models, with translation of findings back to clinical practice

KIWE Trial

EDIBLE

DAiSY